Microbiology

  1. SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes

    1. Paulina Pawlica
    2. Therese A. Yario
    3. Sylvia White
    4. Jianhui Wang
    5. Walter N. Moss
    6. Pei Hui
    7. Joseph M. Vinetz
    8. Joan A. Steitz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. An anti-SARS-CoV-2 non-neutralizing antibody with Fc-effector function defines a new NTD epitope and delays neuroinvasion and death in K18-hACE2 mice

    1. Guillaume Beaudoin-Bussières
    2. Yaozong Chen
    3. Irfan Ullah
    4. Jérémie Prévost
    5. William D. Tolbert
    6. Kelly Symmes
    7. Shilei Ding
    8. Mehdi Benlarbi
    9. Shang Yu Gong
    10. Alexandra Tauzin
    11. Romain Gasser
    12. Debashree Chatterjee
    13. Dani Vézina
    14. Guillaume Goyette
    15. Jonathan Richard
    16. Fei Zhou
    17. Leonidas Stamatatos
    18. Andrew T. McGuire
    19. Hughes Charest
    20. Michel Roger
    21. Edwin Pozharski
    22. Priti Kumar
    23. Walther Mothes
    24. Pradeep D. Uchil
    25. Marzena Pazgier
    26. Andrés Finzi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. A morphological transformation in respiratory syncytial virus leads to enhanced complement deposition

    1. Jessica P Kuppan
    2. Margaret D Mitrovich
    3. Michael D Vahey

    • Curated by eLife

      Evaluation Summary:

      This paper is of broad interest to virologists, immunologists, and structural biologists as it provides new insights into how the biophysical properties of viruses shape the development of immune responses. Overall, the data presented support key claims of the paper, and the strengths and limitations of the approach are properly acknowledged. However, the working model and its implications could be clarified and extended.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 and Reviewer #2 agreed to share their names with the authors.)

    Reviewed by eLife

    5 evaluationsAppears in 1 listLatest version Latest activity

  4. Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum

    1. Keiya Uriu
    2. Izumi Kimura
    3. Kotaro Shirakawa
    4. Akifumi Takaori-Kondo
    5. Taka-aki Nakada
    6. Atsushi Kaneda
    7. So Nakagawa
    8. Kei Sato

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. SARS-CoV-2 originated from SARS-CoV-1-related Bat-CoVs through Pan-CoVs rather than from SARS-CoV-2-related Bat-CoVs

    1. Perumal Arumugam Desingu
    2. K. Nagarajan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22)

    1. Xilin Wu
    2. Yaxing Wang
    3. Lin Cheng
    4. Fengfeng Ni
    5. Linjing Zhu
    6. Sen Ma
    7. Bilian Huang
    8. Mengmeng Ji
    9. Huimin Hu
    10. Yuncheng Li
    11. Shijie Xu
    12. Haixia Shi
    13. Doudou Zhang
    14. Linshuo Liu
    15. Waqas Nawaz
    16. Qinxue Hu
    17. Sheng Ye
    18. Yalan Liu
    19. Zhiwei Wu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Wildlife in Cameroon harbor diverse coronaviruses, including many closely related to human coronavirus 229E

    1. Nkom F Ntumvi
    2. Valantine Ngum Ndze
    3. Amethyst Gillis
    4. Joseph Le Doux Diffo
    5. Ubald Tamoufe
    6. Jean-Michel Takuo
    7. Moctar M M Mouiche
    8. Julius Nwobegahay
    9. Matthew LeBreton
    10. Anne W Rimoin
    11. Bradley S Schneider
    12. Corina Monagin
    13. David J McIver
    14. Sanjit Roy
    15. James A Ayukekbong
    16. Karen E Saylors
    17. Damien O Joly
    18. Nathan D Wolfe
    19. Edward M Rubin
    20. Christian E Lange

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Genomic evidence for divergent co-infections of SARS-CoV-2 lineages

    1. Hang-Yu Zhou
    2. Ye-Xiao Cheng
    3. Lin Xu
    4. Jia-Ying Li
    5. Chen-Yue Tao
    6. Cheng-Yang Ji
    7. Na Han
    8. Rong Yang
    9. Yaling Li
    10. Aiping Wu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters

    1. Kyle L. O’Donnell
    2. Chad S. Clancy
    3. Amanda J. Griffin
    4. Kyle Shifflett
    5. Tylisha Gourdine
    6. Tina Thomas
    7. Carrie M. Long
    8. Wakako Furuyama
    9. Andrea Marzi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19

    1. Xian Lin
    2. Xianliang Ke
    3. Xiaoqin Jian
    4. Lin Xia
    5. Yang Yang
    6. Tianying Zhang
    7. Hualong Xiong
    8. Binghai Zhao
    9. Wen Liu
    10. Quanjiao Chen
    11. Chong Tang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 138 of 252 Next